These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26060292)

  • 1. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Clostridium difficile infections with acid suppression medications in children.
    Nylund CM; Eide M; Gorman GH
    J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients.
    Brown KE; Knoderer CA; Nichols KR; Crumby AS
    Clin Pediatr (Phila); 2015 Oct; 54(11):1102-6. PubMed ID: 25644650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
    JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Community-Associated Clostridium difficile Infection in Children.
    Adams DJ; Eberly MD; Rajnik M; Nylund CM
    J Pediatr; 2017 Jul; 186():105-109. PubMed ID: 28396027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
    Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
    Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
    Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
    Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS
    J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.